National Institute of Rheumatic Diseases, Nábrežie I. Krasku 4, 921 01 Piešťany, Slovakia.
Rheumatol Int. 2011 Apr;31(4):507-11. doi: 10.1007/s00296-009-1258-z. Epub 2009 Dec 23.
The purpose of this study was to evaluate the effect of β-(1,3/1,6)-D: -glucan isolated from Pleurotus ostreatus (β-glucan-PO) on prophylactic treatment of adjuvant arthritis (AA) with methotrexate (MTX) in rats. Groups of rats with AA were treated with methotrexate (1 mg/kg/week), β-glucan-PO (1 mg/kg every second day) or their combination for the period of 28 days from adjuvant application. Body mass, hind paw swelling, arthrogram scores and a level of serum albumin were measured as markers of inflammation and arthritis. Treatment with low dose of MTX significantly inhibited the markers of both inflammation and arthritis. MTX and its combination with β-glucan-PO significantly increased body mass of arthritic rats. β-glucan-PO administered alone significantly decreased both the hind paw swelling and arthritic score. In combination with MTX, β-glucan-PO markedly potentiated the beneficial effects of MTX, which resulted in a more significant reduction of hind paw swelling and arthritic scores. The concentration of albumin in the serum of arthritic controls was significantly lower than in healthy controls. Both MTX alone and the combination treatment with MTX + β-glucan-PO significantly inhibited the decrease in serum albumin. β-Glucan-PO increased the treatment efficacy of basal treatment of AA with MTX.
本研究旨在评估从糙皮侧耳(β-葡聚糖-PO)中分离出的β-(1,3/1,6)-D:-葡聚糖对用甲氨蝶呤(MTX)预防治疗佐剂性关节炎(AA)的影响。AA 大鼠模型分别接受甲氨蝶呤(1mg/kg/周)、β-葡聚糖-PO(1mg/kg 每两天一次)或两者联合治疗 28 天,从佐剂应用开始。体重、后爪肿胀、关节造影评分和血清白蛋白水平作为炎症和关节炎的标志物进行测量。低剂量 MTX 治疗显著抑制了炎症和关节炎的标志物。MTX 及其与 β-葡聚糖-PO 的联合治疗显著增加了关节炎大鼠的体重。单独使用 β-葡聚糖-PO 可显著降低后爪肿胀和关节炎评分。与 MTX 联合使用时,β-葡聚糖-PO 明显增强了 MTX 的有益作用,导致后爪肿胀和关节炎评分的降低更为显著。关节炎对照组血清白蛋白浓度明显低于健康对照组。单独使用 MTX 和 MTX+β-葡聚糖-PO 联合治疗均显著抑制了血清白蛋白的下降。β-葡聚糖-PO 提高了 MTX 对 AA 的基础治疗效果。